{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T02:41:37Z","timestamp":1791081697644,"version":"4.1.0"},"reference-count":86,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,6,12]],"date-time":"2025-06-12T00:00:00Z","timestamp":1749686400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,6,12]],"date-time":"2025-06-12T00:00:00Z","timestamp":1749686400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001775","name":"University of Technology Sydney","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100001775","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Biol Rep"],"published-print":{"date-parts":[[2025,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Silicosis, a form of lung fibrosis (LF), remains a major global health concern because there are few effective ways to diagnose or treat it. Due to their potential function as diagnostic markers and modulators of cancer, exosomal miRNAs are notably featured in more recent advancements. Such exosomal miRNAs offer an invasive approach to diagnosing an illness\u2019s early and accurate nature as they are more stable and measurable in biofluids while illustrating novel cellular changes. Their roles point out this capacity to alter specific molecular processes related to the development of silicosis, such as inflammation, fibrosis, and immunomodulation. Hence, it is possible to find therapeutic targets to decrease fibrosis and diagnostic markers to assess the progression of the disease in these molecules. Recent studies indicate they are involved in fibroblast to myofibroblast transition, macrophage activation in silica, and aberrant signalling such as TGF-\u03b2 and NF-\u03baB. Delivery methods to employ exosomal miRNAs for therapeutic purposes, including replenishment of beneficial miRNAs and targeted change of detrimental ones, are being developed based on these findings. Nevertheless, when these developments apply to these discoveries in clinical practice, questions about factors such as possible scale, standardisation, and targeting services distribution arise. The diagnostic and treatment possibilities of exosomal miRNAs in LF connected to silicosis are investigated in the present study, with characteristics of revolutionary values and gaps filling the current scale of knowledge in the treatment of silicosis and other similar diseases.<\/jats:p>","DOI":"10.1007\/s11033-025-10687-w","type":"journal-article","created":{"date-parts":[[2025,6,12]],"date-time":"2025-06-12T04:07:30Z","timestamp":1749701250000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Exosomal miRNAs as biomarkers and therapeutic targets in silicosis-related lung fibrosis"],"prefix":"10.1007","volume":"52","author":[{"given":"Gaurav","family":"Gupta","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahsas","family":"Goyal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Baby","family":"Ilma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. M.","family":"Rekha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Priya Priyadarshini","family":"Nayak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mandeep","family":"Kaur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anil","family":"Khachi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kavita","family":"Goyal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohit","family":"Rana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Rekha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dennis","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kamal","family":"Dua","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,6,12]]},"reference":[{"key":"10687_CR1","doi-asserted-by":"crossref","unstructured":"Leung CC, Yu IT, Chen W (2012) Silicosis Lancet 379(9830):2008\u20132018","DOI":"10.1016\/S0140-6736(12)60235-9"},{"key":"10687_CR2","doi-asserted-by":"crossref","unstructured":"Hussain MS et al (2025) Targeting CXCR2 signaling in inflammatory lung diseases: neutrophil-driven inflammation and emerging therapies. Naunyn Schmiedebergs Arch Pharmacol","DOI":"10.1007\/s00210-025-03970-x"},{"key":"10687_CR3","doi-asserted-by":"crossref","first-page":"100118","DOI":"10.1016\/j.bea.2024.100118","volume":"7","author":"JC Ku","year":"2024","unstructured":"Ku JC, Raiten J, Li Y (2024) Understanding fibrosis: mechanisms, clinical implications, current therapies, and prospects for future interventions. Biomedical Eng Adv 7:100118","journal-title":"Biomedical Eng Adv"},{"key":"10687_CR4","doi-asserted-by":"crossref","unstructured":"Gupta G et al (2025) Caspase-independent cell death in lung cancer: from mechanisms to clinical applications. Naunyn Schmiedebergs Arch Pharmacol","DOI":"10.1007\/s00210-025-04149-0"},{"key":"10687_CR5","doi-asserted-by":"crossref","unstructured":"Li R, Kang H, Chen S (2023) From basic research to clinical practice: considerations for treatment drugs for silicosis. Int J Mol Sci, 24(9)","DOI":"10.3390\/ijms24098333"},{"key":"10687_CR6","first-page":"1238","volume":"23","author":"AB Saeid","year":"2024","unstructured":"Saeid AB et al (2024) Fisetin-loaded nanoemulsion ameliorates lung cancer pathogenesis via downregulating cathepsin-B, galectin-3 and enolase in an in vitro setting. Excli J 23:1238\u20131244","journal-title":"Excli J"},{"issue":"1","key":"10687_CR7","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/s12995-023-00379-1","volume":"18","author":"MP Rupani","year":"2023","unstructured":"Rupani MP (2023) Challenges and opportunities for silicosis prevention and control: need for a National health program on silicosis in India. J Occup Med Toxicol 18(1):11","journal-title":"J Occup Med Toxicol"},{"issue":"2","key":"10687_CR8","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1007\/s10522-025-10208-z","volume":"26","author":"R Thapa","year":"2025","unstructured":"Thapa R et al (2025) Hypoxia-inducible factor and cellular senescence in pulmonary aging and disease. Biogerontology 26(2):64","journal-title":"Biogerontology"},{"issue":"3","key":"10687_CR9","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1002\/hep.32378","volume":"76","author":"SS Rogal","year":"2022","unstructured":"Rogal SS et al (2022) AASLD practice guidance: palliative care and symptom-based management in decompensated cirrhosis. Hepatology 76(3):819\u2013853","journal-title":"Hepatology"},{"key":"10687_CR10","doi-asserted-by":"crossref","unstructured":"Hussain MS et al (2025) Pharmacological, computational, and mechanistic insights into triptolide\u2019s role in targeting drug-resistant cancers. Naunyn Schmiedebergs Arch Pharmacol","DOI":"10.1007\/s00210-025-03809-5"},{"issue":"28","key":"10687_CR11","doi-asserted-by":"crossref","first-page":"2135","DOI":"10.1038\/s41388-024-03076-3","volume":"43","author":"GAD Metcalf","year":"2024","unstructured":"Metcalf GAD (2024) MicroRNAs: Circulating biomarkers for the early detection of imperceptible cancers via biosensor and machine-learning advances. Oncogene 43(28):2135\u20132142","journal-title":"Oncogene"},{"key":"10687_CR12","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.actbio.2019.02.031","volume":"89","author":"T Li","year":"2019","unstructured":"Li T et al (2019) Recent advancements in mesoporous silica nanoparticles towards therapeutic applications for cancer. Acta Biomater 89:1\u201313","journal-title":"Acta Biomater"},{"key":"10687_CR13","doi-asserted-by":"crossref","unstructured":"Albadrani M (2023) Exploring the impact of silicosis incidence on tuberculosis mortality and morbidity: A Multi-Country study. Med Sci (Basel), 11(4)","DOI":"10.3390\/medsci11040063"},{"key":"10687_CR14","doi-asserted-by":"crossref","unstructured":"Xiao Y et al (2024) Exosome-Derived microRNA: Potential Target for Diagnosis and Treatment of Sepsis. J Immunol Res, 2024: p. 4481452","DOI":"10.1155\/2024\/4481452"},{"issue":"1","key":"10687_CR15","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1038\/s41392-020-00258-9","volume":"5","author":"B Zhou","year":"2020","unstructured":"Zhou B et al (2020) Application of exosomes as liquid biopsy in clinical diagnosis. Signal Transduct Target Ther 5(1):144","journal-title":"Signal Transduct Target Ther"},{"key":"10687_CR16","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/j.omtn.2023.03.021","volume":"32","author":"E Martino","year":"2023","unstructured":"Martino E et al (2023) MicroRNA-nanoparticles against cancer: opportunities and challenges for personalized medicine. Mol Therapy - Nucleic Acids 32:371\u2013384","journal-title":"Mol Therapy - Nucleic Acids"},{"key":"10687_CR17","doi-asserted-by":"crossref","unstructured":"Sidhom K, Obi PO, Saleem A (2020) A review of Exosomal isolation methods: is size exclusion chromatography the best option?? Int J Mol Sci, 21(18)","DOI":"10.3390\/ijms21186466"},{"issue":"2","key":"10687_CR18","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1111\/all.15111","volume":"77","author":"Y Zhou","year":"2022","unstructured":"Zhou Y et al (2022) Regulatory roles of three miRNAs on allergen mRNA expression in tyrophagus putrescentiae. Allergy 77(2):469\u2013482","journal-title":"Allergy"},{"key":"10687_CR19","doi-asserted-by":"crossref","first-page":"26533","DOI":"10.3402\/jev.v4.26533","volume":"4","author":"LC Laurent","year":"2015","unstructured":"Laurent LC et al (2015) Meeting report: discussions and preliminary findings on extracellular RNA measurement methods from laboratories in the NIH extracellular RNA communication consortium. J Extracell Vesicles 4:26533","journal-title":"J Extracell Vesicles"},{"issue":"8","key":"10687_CR20","doi-asserted-by":"crossref","first-page":"e13835","DOI":"10.1111\/pai.13835","volume":"33","author":"Y Zhou","year":"2022","unstructured":"Zhou Y et al (2022) Dermatophagoides Pteronyssinus allergen der p 22: cloning, expression, IgE-binding in asthmatic children, and immunogenicity. Pediatr Allergy Immunol 33(8):e13835","journal-title":"Pediatr Allergy Immunol"},{"key":"10687_CR21","doi-asserted-by":"crossref","unstructured":"Seyhan AA (2024) Trials and tribulations of MicroRNA therapeutics. Int J Mol Sci, 25(3)","DOI":"10.3390\/ijms25031469"},{"key":"10687_CR22","doi-asserted-by":"crossref","first-page":"1321576","DOI":"10.3389\/fendo.2023.1321576","volume":"14","author":"Y Jiang","year":"2024","unstructured":"Jiang Y et al (2024) Endocrine and metabolic factors and the risk of idiopathic pulmonary fibrosis: a Mendelian randomization study. Front Endocrinol 14:1321576","journal-title":"Front Endocrinol"},{"issue":"5","key":"10687_CR23","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1021\/acs.chemrestox.0c00051","volume":"33","author":"JG Cronin","year":"2020","unstructured":"Cronin JG et al (2020) Nanomaterials and innate immunity: A perspective of the current status in nanosafety. Chem Res Toxicol 33(5):1061\u20131073","journal-title":"Chem Res Toxicol"},{"key":"10687_CR24","doi-asserted-by":"crossref","unstructured":"Tang J et al (2017) Spermidine-mediated Poly (lactic-co-glycolic acid) nanoparticles containing fluorofenidone for the treatment of idiopathic pulmonary fibrosis. Int J Nanomed,: p. 6687\u20136704","DOI":"10.2147\/IJN.S140569"},{"issue":"20","key":"10687_CR25","doi-asserted-by":"crossref","first-page":"3861","DOI":"10.1007\/s00018-016-2268-0","volume":"73","author":"NX Land\u00e9n","year":"2016","unstructured":"Land\u00e9n NX, Li D, St\u00e5hle M (2016) Transition from inflammation to proliferation: a critical step during wound healing. Cell Mol Life Sci 73(20):3861\u20133885","journal-title":"Cell Mol Life Sci"},{"key":"10687_CR26","doi-asserted-by":"crossref","first-page":"865065","DOI":"10.3389\/fphar.2022.865065","volume":"13","author":"P Bing","year":"2022","unstructured":"Bing P, Zhou W, Tan S (2022) Study on the mechanism of astragalus polysaccharide in treating pulmonary fibrosis based on Drug-Target-Pathway network. Front Pharmacol 13:865065","journal-title":"Front Pharmacol"},{"issue":"7","key":"10687_CR27","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1089\/ars.2012.5149","volume":"20","author":"M Mittal","year":"2014","unstructured":"Mittal M et al (2014) Reactive oxygen species in inflammation and tissue injury. Antioxid Redox Signal 20(7):1126\u20131167","journal-title":"Antioxid Redox Signal"},{"issue":"2","key":"10687_CR28","first-page":"37","volume":"31","author":"X Lin","year":"2016","unstructured":"Lin X et al (2016) Regulation of oncoprotein 18\/stathmin signaling by ERK concerns the resistance to taxol in nonsmall cell lung Cancer cells. Cancer Biother Radiopharm 31(2):37\u201343","journal-title":"Cancer Biother Radiopharm"},{"issue":"3","key":"10687_CR29","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.matbio.2009.11.005","volume":"29","author":"MM Castro","year":"2010","unstructured":"Castro MM et al (2010) Imbalance between matrix metalloproteinases and tissue inhibitor of metalloproteinases in hypertensive vascular remodeling. Matrix Biol 29(3):194\u2013201","journal-title":"Matrix Biol"},{"key":"10687_CR30","doi-asserted-by":"crossref","first-page":"5431","DOI":"10.2147\/DDDT.S282206","volume":"14","author":"C Jiang","year":"2020","unstructured":"Jiang C et al (2020) Xanthohumol inhibits TGF-\u03b21-Induced cardiac fibroblasts activation via mediating pten\/akt\/mtor signaling pathway. Drug Des Devel Ther 14:5431\u20135439","journal-title":"Drug Des Devel Ther"},{"key":"10687_CR31","doi-asserted-by":"crossref","first-page":"883","DOI":"10.3389\/fimmu.2020.00883","volume":"11","author":"AAA Alyaseer","year":"2020","unstructured":"Alyaseer AAA, de Lima MHS, Braga TT (2020) The role of NLRP3 inflammasome activation in the epithelial to mesenchymal transition process during the fibrosis. Front Immunol 11:883","journal-title":"Front Immunol"},{"issue":"5","key":"10687_CR32","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1165\/rcmb.2008-0046OC","volume":"39","author":"RM Gilberti","year":"2008","unstructured":"Gilberti RM, Joshi GN, Knecht DA (2008) The phagocytosis of crystalline silica particles by macrophages. Am J Respir Cell Mol Biol 39(5):619\u2013627","journal-title":"Am J Respir Cell Mol Biol"},{"issue":"1","key":"10687_CR33","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1186\/s12967-024-05399-x","volume":"22","author":"TT Liu","year":"2024","unstructured":"Liu TT et al (2024) Bicyclol attenuates pulmonary fibrosis with silicosis via both canonical and non-canonical TGF-\u03b21 signaling pathways. J Transl Med 22(1):682","journal-title":"J Transl Med"},{"issue":"1","key":"10687_CR34","doi-asserted-by":"crossref","first-page":"13348","DOI":"10.1038\/s41598-021-92587-0","volume":"11","author":"JJ Blanco-P\u00e9rez","year":"2021","unstructured":"Blanco-P\u00e9rez JJ et al (2021) Serum levels of inflammatory mediators as prognostic biomarker in silica exposed workers. Sci Rep 11(1):13348","journal-title":"Sci Rep"},{"key":"10687_CR35","doi-asserted-by":"crossref","first-page":"p5164970","DOI":"10.1155\/2022\/5164970","volume":"2022","author":"S Hussain","year":"2022","unstructured":"Hussain S et al (2022) Modern diagnostic imaging technique applications and risk factors in the medical field: A review. Biomed Res Int 2022:p5164970","journal-title":"Biomed Res Int"},{"issue":"1","key":"10687_CR36","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1186\/s12964-023-01102-7","volume":"21","author":"FNA Jahromi","year":"2023","unstructured":"Jahromi FNA, Dowran R, Jafari R (2023) Recent advances in the roles of Exosomal MicroRNAs (exomiRs) in hematologic neoplasms: pathogenesis, diagnosis, and treatment. Cell Commun Signal 21(1):88","journal-title":"Cell Commun Signal"},{"key":"10687_CR37","doi-asserted-by":"crossref","first-page":"171774","DOI":"10.1016\/j.scitotenv.2024.171774","volume":"925","author":"A Javdani-Mallak","year":"2024","unstructured":"Javdani-Mallak A, Salahshoori I (2024) Environmental pollutants and exosomes: A new paradigm in environmental health and disease. Sci Total Environ 925:171774","journal-title":"Sci Total Environ"},{"issue":"4","key":"10687_CR38","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1007\/s00705-023-05744-3","volume":"168","author":"L Mao","year":"2023","unstructured":"Mao L et al (2023) Roles and mechanisms of Exosomal MicroRNAs in viral infections. Arch Virol 168(4):121","journal-title":"Arch Virol"},{"key":"10687_CR39","doi-asserted-by":"crossref","unstructured":"Wang R et al (2024) The novel insights of epithelial-derived exosomes in various fibrotic diseases, vol 174. Biomedicine & Pharmacotherapy, p 116591","DOI":"10.1016\/j.biopha.2024.116591"},{"key":"10687_CR40","doi-asserted-by":"crossref","unstructured":"Negrete-Garc\u00eda MC et al (2022) Exosomal Micro-RNAs as intercellular communicators in idiopathic pulmonary fibrosis. Int J Mol Sci, 23(19)","DOI":"10.3390\/ijms231911047"},{"key":"10687_CR41","doi-asserted-by":"crossref","unstructured":"Li S et al (2022) The emerging role of extracellular vesicles from mesenchymal stem cells and macrophages in pulmonary fibrosis: insights into MiRNA delivery. Pharmaceuticals (Basel), 15(10)","DOI":"10.3390\/ph15101276"},{"issue":"2","key":"10687_CR42","doi-asserted-by":"crossref","first-page":"H520","DOI":"10.1152\/ajpheart.00373.2020","volume":"320","author":"YC Wang","year":"2021","unstructured":"Wang YC et al (2021) Exosomal miR-107 antagonizes profibrotic phenotypes of pericytes by targeting a pathway involving HIF-1\u03b1\/Notch1\/PDGFR\u03b2\/YAP1\/Twist1 axis in vitro. Am J Physiol Heart Circ Physiol 320(2):H520\u2013h534","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10687_CR43","doi-asserted-by":"crossref","first-page":"131058","DOI":"10.1016\/j.ijbiomac.2024.131058","volume":"266","author":"J Xia","year":"2024","unstructured":"Xia J et al (2024) Exposure to micron-grade silica particles triggers pulmonary fibrosis through cell-to-cell delivery of Exosomal miR-107. Int J Biol Macromol 266:131058","journal-title":"Int J Biol Macromol"},{"key":"10687_CR44","doi-asserted-by":"crossref","first-page":"110253","DOI":"10.1016\/j.ecoenv.2020.110253","volume":"192","author":"D Wang","year":"2020","unstructured":"Wang D et al (2020) Exosomal miR-125a-5p derived from silica-exposed macrophages induces fibroblast transdifferentiation. Ecotoxicol Environ Saf 192:110253","journal-title":"Ecotoxicol Environ Saf"},{"issue":"8","key":"10687_CR45","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1093\/jpp\/rgae058","volume":"76","author":"Y Lou","year":"2024","unstructured":"Lou Y et al (2024) The mechanism of action of Botrychium (Thunb.) sw. for prevention of idiopathic pulmonary fibrosis based on 1H-NMR-based metabolomics. J Pharm Pharmacol 76(8):1018\u20131027","journal-title":"J Pharm Pharmacol"},{"key":"10687_CR46","doi-asserted-by":"crossref","first-page":"115647","DOI":"10.1016\/j.ecoenv.2023.115647","volume":"267","author":"M Ding","year":"2023","unstructured":"Ding M et al (2023) Silica-exposed macrophages-secreted Exosomal miR125a-5p induces Th1\/Th2 and Treg\/Th17 cell imbalance and promotes fibroblast transdifferentiation. Ecotoxicol Environ Saf 267:115647","journal-title":"Ecotoxicol Environ Saf"},{"issue":"11","key":"10687_CR47","doi-asserted-by":"crossref","first-page":"3175","DOI":"10.21037\/tlcr-24-811","volume":"13","author":"S Wang","year":"2024","unstructured":"Wang S et al (2024) Fluorofenidone enhances cisplatin efficacy in non-small cell lung cancer: a novel approach to inhibiting cancer progression. Transl Lung Cancer Res 13(11):3175\u20133188","journal-title":"Transl Lung Cancer Res"},{"issue":"1","key":"10687_CR48","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1186\/s12890-024-03014-9","volume":"24","author":"C Bo","year":"2024","unstructured":"Bo C et al (2024) Simvastatin attenuates silica-induced pulmonary inflammation and fibrosis in rats via the AMPK-NOX pathway. BMC Pulm Med 24(1):224","journal-title":"BMC Pulm Med"},{"key":"10687_CR49","doi-asserted-by":"crossref","first-page":"153310","DOI":"10.1016\/j.tox.2022.153310","volume":"479","author":"Z Niu","year":"2022","unstructured":"Niu Z et al (2022) Macrophage derived miR-7219\u20133p-containing exosomes mediate fibroblast trans-differentiation by targeting SPRY1 in silicosis. Toxicology 479:153310","journal-title":"Toxicology"},{"issue":"1","key":"10687_CR50","doi-asserted-by":"crossref","first-page":"3","DOI":"10.2353\/ajpath.2009.081170","volume":"175","author":"WD Hardie","year":"2009","unstructured":"Hardie WD, Glasser SW, Hagood JS (2009) Emerging concepts in the pathogenesis of lung fibrosis. Am J Pathol 175(1):3\u201316","journal-title":"Am J Pathol"},{"key":"10687_CR51","doi-asserted-by":"crossref","first-page":"136629","DOI":"10.1016\/j.jhazmat.2024.136629","volume":"483","author":"L Zhang","year":"2025","unstructured":"Zhang L et al (2025) Exosomal MiRNA reprogramming in pyroptotic macrophage drives silica-induced fibroblast-to-myofibroblast transition and pulmonary fibrosis. J Hazard Mater 483:136629","journal-title":"J Hazard Mater"},{"key":"10687_CR52","doi-asserted-by":"crossref","first-page":"116971","DOI":"10.1016\/j.ecoenv.2024.116971","volume":"283","author":"S Chang","year":"2024","unstructured":"Chang S et al (2024) Exosome MiRNA profile and mitigating effect of miR-23a-3p\/Cul3 axis on apoptosis in the pathogenesis of SiO2 dust-induced lung fibrosis. Ecotoxicol Environ Saf 283:116971","journal-title":"Ecotoxicol Environ Saf"},{"key":"10687_CR53","doi-asserted-by":"crossref","unstructured":"Zhou H et al (2024) NLRP3 inflammasome mediates abnormal epithelial regeneration and distal lung remodeling in silica\u2013induced lung fibrosis. Int J Mol Med, 53(3)","DOI":"10.3892\/ijmm.2024.5349"},{"key":"10687_CR54","doi-asserted-by":"crossref","first-page":"109476","DOI":"10.1016\/j.intimp.2022.109476","volume":"114","author":"Q Zhang","year":"2023","unstructured":"Zhang Q et al (2023) The aggravate role of Exosomal circRNA11:120406118|12040782 on macrophage pyroptosis through miR-30b-5p\/NLRP3 axis in silica-induced lung fibrosis. Int Immunopharmacol 114:109476","journal-title":"Int Immunopharmacol"},{"issue":"13","key":"10687_CR55","doi-asserted-by":"crossref","first-page":"2895","DOI":"10.1084\/jem.20061536","volume":"203","author":"XM Wang","year":"2006","unstructured":"Wang XM et al (2006) Caveolin-1: a critical regulator of lung fibrosis in idiopathic pulmonary fibrosis. J Exp Med 203(13):2895\u20132906","journal-title":"J Exp Med"},{"key":"10687_CR56","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.toxlet.2024.08.013","volume":"401","author":"M Li","year":"2024","unstructured":"Li M et al (2024) Exosomal miR-552-3p isolated from BALF of patients with silicosis induces fibroblast activation. Toxicol Lett 401:55\u201370","journal-title":"Toxicol Lett"},{"key":"10687_CR57","doi-asserted-by":"crossref","first-page":"1362509","DOI":"10.3389\/fphar.2024.1362509","volume":"15","author":"TT Liu","year":"2024","unstructured":"Liu TT et al (2024) The role of inflammation in silicosis. Front Pharmacol 15:1362509","journal-title":"Front Pharmacol"},{"key":"10687_CR58","doi-asserted-by":"crossref","unstructured":"Fan J et al (2024) Comparative analysis of gut microbiota in incident and prevalent peritoneal dialysis patients with peritoneal fibrosis, correlations with peritoneal equilibration test data in the peritoneal fibrosis cohort. Ther Apher Dial","DOI":"10.1111\/1744-9987.14226"},{"key":"10687_CR59","doi-asserted-by":"crossref","first-page":"911945","DOI":"10.3389\/fphar.2022.911945","volume":"13","author":"J Min","year":"2022","unstructured":"Min J et al (2022) TRAF6 suppresses the development of pulmonary fibrosis by attenuating the activation of fibroblasts. Front Pharmacol 13:911945","journal-title":"Front Pharmacol"},{"key":"10687_CR60","doi-asserted-by":"crossref","first-page":"113302","DOI":"10.1016\/j.ecoenv.2022.113302","volume":"233","author":"C Xu","year":"2022","unstructured":"Xu C et al (2022) Exosomal let-7i-5p from three-dimensional cultured human umbilical cord mesenchymal stem cells inhibits fibroblast activation in silicosis through targeting TGFBR1. Ecotoxicol Environ Saf 233:113302","journal-title":"Ecotoxicol Environ Saf"},{"issue":"5","key":"10687_CR61","doi-asserted-by":"crossref","first-page":"e37286","DOI":"10.1371\/journal.pone.0037286","volume":"7","author":"L Song","year":"2012","unstructured":"Song L et al (2012) Tregs promote the differentiation of Th17 cells in silica-induced lung fibrosis in mice. PLoS ONE 7(5):e37286","journal-title":"PLoS ONE"},{"key":"10687_CR62","doi-asserted-by":"crossref","first-page":"112466","DOI":"10.1016\/j.intimp.2024.112466","volume":"137","author":"R Wang","year":"2024","unstructured":"Wang R et al (2024) Exosome microRNA-125a-5p derived from epithelium promotes M1 macrophage polarization by targeting IL1RN in chronic obstructive pulmonary disease. Int Immunopharmacol 137:112466","journal-title":"Int Immunopharmacol"},{"key":"10687_CR63","doi-asserted-by":"crossref","first-page":"114401","DOI":"10.1016\/j.ecoenv.2022.114401","volume":"249","author":"M Ding","year":"2023","unstructured":"Ding M et al (2023) Exosomal miR-125a-5p regulates T lymphocyte subsets to promote silica-induced pulmonary fibrosis by targeting TRAF6. Ecotoxicol Environ Saf 249:114401","journal-title":"Ecotoxicol Environ Saf"},{"issue":"7","key":"10687_CR64","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1038\/mt.2016.90","volume":"24","author":"B Wang","year":"2016","unstructured":"Wang B et al (2016) Mesenchymal stem cells deliver exogenous MicroRNA-let7c via exosomes to attenuate renal fibrosis. Mol Ther 24(7):1290\u20131301","journal-title":"Mol Ther"},{"issue":"49","key":"10687_CR65","doi-asserted-by":"crossref","first-page":"35428","DOI":"10.1074\/jbc.M112.426866","volume":"288","author":"S Banerjee","year":"2013","unstructured":"Banerjee S et al (2013) miR-125a-5p regulates differential activation of macrophages and inflammation. J Biol Chem 288(49):35428\u201335436","journal-title":"J Biol Chem"},{"issue":"5","key":"10687_CR66","doi-asserted-by":"crossref","first-page":"436","DOI":"10.3892\/etm.2021.9853","volume":"21","author":"P Yao","year":"2021","unstructured":"Yao P et al (2021) miR-23a-3p regulates the proliferation and apoptosis of human lens epithelial cells by targeting Bcl-2 in an in vitro model of cataracts. Exp Ther Med 21(5):436","journal-title":"Exp Ther Med"},{"key":"10687_CR67","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1016\/j.omtn.2019.04.027","volume":"16","author":"M Wang","year":"2019","unstructured":"Wang M et al (2019) Emerging function and clinical values of Exosomal MicroRNAs in Cancer. Mol Ther Nucleic Acids 16:791\u2013804","journal-title":"Mol Ther Nucleic Acids"},{"key":"10687_CR68","doi-asserted-by":"crossref","unstructured":"Bakhsh T et al (2022) Exosomal miRNAs as a promising source of biomarkers in colorectal Cancer progression. Int J Mol Sci, 23(9)","DOI":"10.3390\/ijms23094855"},{"issue":"Pt 1","key":"10687_CR69","doi-asserted-by":"crossref","first-page":"131058","DOI":"10.1016\/j.ijbiomac.2024.131058","volume":"266","author":"J Xia","year":"2024","unstructured":"Xia J et al (2024) Exposure to micron-grade silica particles triggers pulmonary fibrosis through cell-to-cell delivery of Exosomal miR-107. Int J Biol Macromol 266(Pt 1):131058","journal-title":"Int J Biol Macromol"},{"key":"10687_CR70","doi-asserted-by":"crossref","first-page":"560025","DOI":"10.3389\/fonc.2020.560025","volume":"10","author":"Z Zhang","year":"2020","unstructured":"Zhang Z et al (2020) Tumor-Derived Exosomal miRNAs as diagnostic biomarkers in Non-Small cell lung Cancer. Front Oncol 10:560025","journal-title":"Front Oncol"},{"key":"10687_CR71","doi-asserted-by":"crossref","unstructured":"Kan JY et al (2024) Exosomal microRNA-92b is a diagnostic biomarker in breast Cancer and targets Survival-Related MTSS1L to promote tumorigenesis. Int J Mol Sci, 25(2)","DOI":"10.3390\/ijms25021295"},{"key":"10687_CR72","doi-asserted-by":"crossref","unstructured":"Feng Y et al (2024) Mesenchymal stem cell-derived exosomes as delivery vehicles for non-coding RNAs in lung diseases, vol 170. Biomedicine & Pharmacotherapy, p 116008","DOI":"10.1016\/j.biopha.2023.116008"},{"key":"10687_CR73","doi-asserted-by":"crossref","first-page":"927653","DOI":"10.3389\/fphar.2022.927653","volume":"13","author":"Y Yang","year":"2022","unstructured":"Yang Y et al (2022) Exosomes in pathogenesis, diagnosis, and treatment of pulmonary fibrosis. Front Pharmacol 13:927653","journal-title":"Front Pharmacol"},{"key":"10687_CR74","doi-asserted-by":"crossref","unstructured":"Yang T et al (2022) Current and prospective applications of Exosomal MicroRNAs in pulmonary fibrosis (Review). Int J Mol Med, 49(3)","DOI":"10.3892\/ijmm.2022.5092"},{"key":"10687_CR75","doi-asserted-by":"crossref","unstructured":"Hao X et al (2024) Mesenchymal stem Cell-Exosomal miR-99a attenuate Silica-Induced lung fibrosis by inhibiting pulmonary fibroblast transdifferentiation. Int J Mol Sci, 25(23)","DOI":"10.3390\/ijms252312626"},{"issue":"11","key":"10687_CR76","doi-asserted-by":"crossref","first-page":"108282","DOI":"10.1016\/j.isci.2023.108282","volume":"26","author":"W Cheng","year":"2023","unstructured":"Cheng W et al (2023) Engineered extracellular vesicles: A potential treatment for regeneration. iScience 26(11):108282","journal-title":"iScience"},{"key":"10687_CR77","doi-asserted-by":"crossref","first-page":"1382398","DOI":"10.3389\/fonc.2024.1382398","volume":"14","author":"C Si","year":"2024","unstructured":"Si C, Gao J, Ma X (2024) Engineered exosomes in emerging cell-free therapy. Front Oncol 14:1382398","journal-title":"Front Oncol"},{"key":"10687_CR78","doi-asserted-by":"crossref","unstructured":"Youssef E et al (2025) Exosomes in precision oncology and beyond: from bench to bedside in diagnostics and therapeutics. Cancers (Basel), 17(6)","DOI":"10.3390\/cancers17060940"},{"key":"10687_CR79","doi-asserted-by":"crossref","unstructured":"Dehghani S et al (2025) Exosomes as biomarkers and therapeutic agents in neurodegenerative diseases: current insights and future directions. Molecular Neurobiology","DOI":"10.1007\/s12035-025-04825-5"},{"issue":"23","key":"10687_CR80","doi-asserted-by":"crossref","first-page":"5803","DOI":"10.1039\/D4NA00501E","volume":"6","author":"SS Palakurthi","year":"2024","unstructured":"Palakurthi SS et al (2024) A comprehensive review of challenges and advances in exosome-based drug delivery systems. Nanoscale Adv 6(23):5803\u20135826","journal-title":"Nanoscale Adv"},{"issue":"1","key":"10687_CR81","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1186\/s40001-025-02561-z","volume":"30","author":"MJ Saadh","year":"2025","unstructured":"Saadh MJ et al (2025) Exosomes and micrornas: key modulators of macrophage polarization in sepsis pathophysiology. Eur J Med Res 30(1):298","journal-title":"Eur J Med Res"},{"key":"10687_CR82","doi-asserted-by":"crossref","first-page":"63","DOI":"10.3389\/fcvm.2017.00063","volume":"4","author":"GR Willis","year":"2017","unstructured":"Willis GR, Kourembanas S, Mitsialis SA (2017) Toward Exosome-Based therapeutics: isolation, heterogeneity, and Fit-for-Purpose potency. Front Cardiovasc Med 4:63","journal-title":"Front Cardiovasc Med"},{"key":"10687_CR83","doi-asserted-by":"crossref","unstructured":"Kaur G et al (2021) Distinct Exosomal MiRNA profiles from BALF and lung tissue of COPD and IPF patients. Int J Mol Sci, 22(21)","DOI":"10.3390\/ijms222111830"},{"issue":"3","key":"10687_CR84","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1016\/j.ncrna.2023.05.004","volume":"8","author":"S Ghafouri-Fard","year":"2023","unstructured":"Ghafouri-Fard S et al (2023) Emerging functions and clinical applications of Exosomal MicroRNAs in diseases. Noncoding RNA Res 8(3):350\u2013362","journal-title":"Noncoding RNA Res"},{"key":"10687_CR85","doi-asserted-by":"crossref","first-page":"101771","DOI":"10.1016\/j.nantod.2023.101771","volume":"49","author":"VP Chavda","year":"2023","unstructured":"Chavda VP et al (2023) Exosome nanovesicles: A potential carrier for therapeutic delivery. Nano Today 49:101771","journal-title":"Nano Today"},{"key":"10687_CR86","doi-asserted-by":"crossref","unstructured":"Koh HB et al (2023) Exosome-Based drug delivery: translation from bench to clinic. Pharmaceutics, 15(8)","DOI":"10.3390\/pharmaceutics15082042"}],"container-title":["Molecular Biology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-025-10687-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11033-025-10687-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-025-10687-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T10:09:26Z","timestamp":1781604566000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11033-025-10687-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,12]]},"references-count":86,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["10687"],"URL":"https:\/\/doi.org\/10.1007\/s11033-025-10687-w","relation":{},"ISSN":["0301-4851","1573-4978"],"issn-type":[{"value":"0301-4851","type":"print"},{"value":"1573-4978","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,12]]},"assertion":[{"value":"23 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 June 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 June 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Consent to publish has been obtained from all authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"585"}}